Short answer
GE HealthCare (GEHC) filed an 8-K current report with the SEC on July 23, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1). Preliminary unaudited revenue and EPS results announced for second quarter 2026.
GE HealthCare 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Preliminary unaudited revenue and EPS results announced for second quarter 2026
- GE HealthCare furnished the earnings press release as Exhibit 99
- Investors should review Exhibit 99 for reported financial figures and management commentary
Item 5.02 · Departure/Election of Directors or Officers
- CFO Jay Saccaro resigning August 14, 2026 for an external role outside medical technology
- George Newcomb appointed interim CFO while permanent successor search begins
- Newcomb retains Controller and Chief Accounting Officer roles, concentrating finance responsibilities
- No compensation changes or reportable related-party transactions tied to interim appointment
- Leadership transition creates near-term execution and succession-monitoring risk for investors
Item EX-99.1 · Exhibit EX-99.1
- CFO Jay Saccaro departing August 14, 2026; interim CFO George Newcomb brings 38 years of finance experience
- Preliminary Q2 revenue $5,295 million, up 5.7% year over year
- Organic revenue $5,182 million, up 3.5%, indicating underlying business growth excluding acquisitions and currency
- Diluted EPS and adjusted EPS growth expected above prior expectations
- Full-year 2026 guidance reaffirmed; complete unaudited results due July 29, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other GE HealthCare 8-K filings
Get the next GEHC 8-K as it lands
Follow GEHC for push alerts, or ask the research agent what this filing means.